Cita APA

Drozdzik, M. (., Qian, C. (., Lasarte-Sagastibelza, J. (. J., Bilbao, R. (., & Prieto, J. (. (1998). Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL).

Citación estilo Chicago

Drozdzik, M. (Marek)|||/items/f94b6eeb-69fa-4e8b-99d1-a67fed00a236, C. (Cheng)|||/items/49f586b0-dcc7-4e30-82f4-91f3c38ecc37 Qian, J.J. (Juan José)|||/items/e366ad83-3db4-41ec-a9da-ed9159ba5c0c Lasarte-Sagastibelza, R. (Roberto)|||/items/b0d248ab-bfb5-45c1-b33c-1d045bdb9b44 Bilbao, y J. (Jesús)|||/items/0d9c3dec-4a09-400d-8c83-23ece1096c71 Prieto. Antitumor Effect of Allogenic Fibroblasts Engineered to Express Fas Ligand (FasL). 1998.

Cita MLA

Drozdzik, M. (Marek)|||/items/f94b6eeb-69fa-4e8b-99d1-a67fed00a236, et al. Antitumor Effect of Allogenic Fibroblasts Engineered to Express Fas Ligand (FasL). 1998.